Pulsenmore Ltd.
- Last sale
- Nov 12, 2026 · -5.00%
- Market cap
- $9.88M
- 6.5M shares
- Filings
- 52
FY 2025
—FY 2025
——
—
—FY 2025derived
—FY 2025
—FY 2025−47.5% FY25 yoy
- $9.88M
- —
- 0.8×
- 0.4×
- -104.69%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $12,547,000 | reported |
Surgical & medical instruments & apparatus
Pulsenmore Ltd. is the 86th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
VVOSVivos Therapeutics, Inc.$17.4M16.0%121.4%$1.9MPROFProfound Medical Corp.$16.1M65.3%264.4%$270.7MBTCYBiotricity Inc.$16.0M16.0%15.0%$995.7KALURAllurion Technologies, Inc.$15.2M52.6%188.8%—
PLSMPulsenmore Ltd. (this company)$12.5M—39.6%$9.9M
NXGLNexgel, Inc.$11.4M31.5%26.3%$35.6MWOKWORK Medical Technology Group LTD$9.8M14.4%10.9%—MDNCMedinotec Inc.$9.7M6.8%8.2%—NMTCNeuroone Medical Technologies Corp$9.1M163.5%39.6%$6.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Pulsenmore Ltd. · CIK 2064764 · Engraved from SEC EDGAR